Nordea Investment Management’s Rocket Pharmaceuticals RCKT Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $659K | Buy |
263,746
+9,341
| +4% | +$23.4K | ﹤0.01% | 843 |
|
2025
Q1 | $1.67M | Buy |
254,405
+127,135
| +100% | +$833K | ﹤0.01% | 723 |
|
2024
Q4 | $1.6M | Buy |
127,270
+501
| +0.4% | +$6.29K | ﹤0.01% | 722 |
|
2024
Q3 | $2.35M | Sell |
126,769
-5,717
| -4% | -$106K | ﹤0.01% | 665 |
|
2024
Q2 | $2.76M | Sell |
132,486
-21,584
| -14% | -$450K | ﹤0.01% | 641 |
|
2024
Q1 | $4.14M | Buy |
154,070
+1,209
| +0.8% | +$32.5K | ﹤0.01% | 582 |
|
2023
Q4 | $4.66M | Sell |
152,861
-5,710
| -4% | -$174K | 0.01% | 539 |
|
2023
Q3 | $3.25M | Sell |
158,571
-4,201
| -3% | -$86.2K | ﹤0.01% | 610 |
|
2023
Q2 | $3.33M | Sell |
162,772
-54,294
| -25% | -$1.11M | ﹤0.01% | 603 |
|
2023
Q1 | $3.62M | Sell |
217,066
-21,768
| -9% | -$363K | 0.01% | 584 |
|
2022
Q4 | $4.65M | Sell |
238,834
-6,803
| -3% | -$132K | 0.01% | 535 |
|
2022
Q3 | $3.71M | Sell |
245,637
-1,131
| -0.5% | -$17.1K | 0.01% | 587 |
|
2022
Q2 | $3.11M | Sell |
246,768
-25,963
| -10% | -$327K | ﹤0.01% | 635 |
|
2022
Q1 | $4.46M | Buy |
272,731
+2,927
| +1% | +$47.8K | 0.01% | 608 |
|
2021
Q4 | $6.23M | Sell |
269,804
-2,464
| -0.9% | -$56.9K | 0.01% | 540 |
|
2021
Q3 | $8.19M | Buy |
272,268
+92,585
| +52% | +$2.79M | 0.01% | 459 |
|
2021
Q2 | $7.96M | Buy |
+179,683
| New | +$7.96M | 0.01% | 464 |
|